Fiduciary Group’s AstraZeneca AZN Stock Holding History

Fiduciary Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.24M	Buy	26,565 +462	+2%	+$89.1K	0.45%	60
2025 Q4	$4.8M	Buy	26,103 +198	+0.8%	+$34.7K	0.4%	64
2025 Q3	$3.97M	Buy	25,905 +191	+0.7%	+$28.9K	0.35%	70
2025 Q2	$3.59M	Buy	25,714 +67	+0.3%	+$9.39K	0.34%	74
2025 Q1	$3.77M	Buy	25,647 +191	+0.8%	+$27.6K	0.38%	68
2024 Q4	$3.34M	Buy	25,456 +1,958	+8%	+$274K	0.33%	73
2024 Q3	$3.66M	Buy	23,498 +157	+0.7%	+$25.3K	0.37%	72
2024 Q2	$3.64M	Sell	23,341 -55	-0.2%	-$8.28K	0.39%	67
2024 Q1	$3.17M	Buy	23,396 +2,143	+10%	+$284K	0.35%	72
2023 Q4	$2.86M	Buy	21,253 +16,165	+318%	+$2.1M	0.34%	75
2023 Q3	$689K	Buy	5,088 +3,607	+244%	+$493K	0.09%	136
2023 Q2	$212K	Buy	+1,481	New	+$218K	0.03%	230

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Fiduciary Group's AZN Position: Q1 2026 in Review

Fiduciary Group increased its AstraZeneca (AZN) stake by 1.8% in Q1 2026, buying an estimated $89.1K and bringing the position to 26,565 shares worth $5.24M. The position accounts for 0.45% of the portfolio, ranked #60.

Fiduciary Group first reported a position in AZN in Q2 2023 and has held it in 12 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Fiduciary Group held 26,565 shares of AstraZeneca worth $5.24M as of Q1 2026.
Fiduciary Group bought 462 AstraZeneca shares in Q1 2026, an estimated $89.1K.
AstraZeneca made up 0.45% of Fiduciary Group's portfolio in Q1 2026, its #60 holding.
Fiduciary Group first reported a position in AstraZeneca in Q2 2023 and has held it in 12 quarters since.
1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Fiduciary Group's 13F filing for Q1 2026, filed 11 May 2026.